Literature DB >> 32454712

Electroanalytical Determination of the Antiinflammatory Drug Tenoxicam in Pharmaceutical Dosage Forms.

Fatma Ağin1, Sena Atal1.   

Abstract

OBJECTIVES: The electro-oxidation behavior of the non-steroidal anti-inflammatory drug tenoxicam (TX) was studied on multiwalled carbon nanotube (MWCNT)-modified glassy carbon electrode (GCE) by cyclic voltammetry, differential pulse voltammetry (DPV), and square wave voltammetry (SWV).
MATERIALS AND METHODS: The GCE was modified with MWCNT for sensitive determination of TX by voltammetric methods.
RESULTS: The current peaks for TX occurred at around 0.520 V for DPV and 0.570 V for SWV when the potential was scanned in the positive direction. The oxidation process of TX showed irreversible and diffusion-controlled behavior. The linear responses were obtained in the range from 2×10-7 to 1×10-5 M with the limit of detection (LOD) 1.43×10-9 for DPV and from 8×10-9 to 8×10-6 with the LOD 9.97×10-10 for SWV in 1 M acetate buffer solution at pH 5.5.
CONCLUSION: Fully validated DPV and SWV were successfully applied for the determination of TX from pharmaceutical dosage form and yielded satisfying results. ©Copyright 2019 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  Glassy carbon electrode; multiwalled carbon nanotubes; tenoxicam; voltammetry

Year:  2019        PMID: 32454712      PMCID: PMC7227964          DOI: 10.4274/tjps.galenos.2018.60783

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  17 in total

1.  Simultaneous determination of tenoxicam and 2-aminopyridine using derivative spectrophotometry and high-performance liquid chromatography.

Authors:  A F el Walily; S M Blaih; M H Barary; M A el Sayed; H H Abdine; A M el Kersh
Journal:  J Pharm Biomed Anal       Date:  1997-08       Impact factor: 3.935

2.  Spectrophotometric determination of piroxicam and tenoxicam in pharmaceutical formulations using alizarin.

Authors:  Alaa S Amin
Journal:  J Pharm Biomed Anal       Date:  2002-07-20       Impact factor: 3.935

3.  Spectrofluorimetric determination of 2-aminopyridine as a potential impurity in piroxicam and tenoxicam within the pharmacopoeial limit.

Authors:  Magda H Barary; Mohamed H Abdel-Hay; Suzy M Sabry; Tarek S Belal
Journal:  J Pharm Biomed Anal       Date:  2004-01-27       Impact factor: 3.935

4.  Flow-injection spectrophotometric methods for the determination of tenoxicam.

Authors:  M S García; C Sánchez-Pedreño; M I Albero; M J Gimenez
Journal:  J Pharm Biomed Anal       Date:  1999-12       Impact factor: 3.935

5.  Fast RPLC-UV method on short sub-two microns particles packed column for the assay of tenoxicam in plasma samples.

Authors:  Iulia Sora; Toma Galaon; Stefan Udrescu; Jean Negru; Victor David; Andrei Medvedovici
Journal:  J Pharm Biomed Anal       Date:  2006-12-04       Impact factor: 3.935

6.  Simple method for the analysis of tenoxicam in human plasma using high-performance liquid chromatography.

Authors:  J L Mason; G J Hobbs
Journal:  J Chromatogr B Biomed Appl       Date:  1995-03-24

7.  Determination of tenoxicam in plasma by high-performance liquid chromatography.

Authors:  M I Múnera-Jaramillo; S Botero-Garcés
Journal:  J Chromatogr       Date:  1993-07-02

8.  Electro-oxidation and determination of antihistamine drug, cetirizine dihydrochloride at glassy carbon electrode modified with multi-walled carbon nanotubes.

Authors:  Roopa H Patil; Rajesh N Hegde; Sharanappa T Nandibewoor
Journal:  Colloids Surf B Biointerfaces       Date:  2010-11-16       Impact factor: 5.268

9.  Investigation of electrochemical behavior of lipid lowering agent atorvastatin calcium in aqueous media and its determination from pharmaceutical dosage forms and biological fluids using boron-doped diamond and glassy carbon electrodes.

Authors:  Burcu Dogan-Topal; Bengi Uslu; Sibel A Ozkan
Journal:  Comb Chem High Throughput Screen       Date:  2007-08       Impact factor: 1.339

10.  Spectrophotometric and potentiometric determination of piroxicam and tenoxicam in pharmaceutical preparations.

Authors:  Mohamed A El-Ries; Gehad Mohamed; Shaeban Khalil; Manal El-Shall
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-01       Impact factor: 1.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.